| Predicted Trait | |
| Reported Trait | Type 2 diabetes (T2D) |
| Mapped Trait(s) | type 2 diabetes mellitus (MONDO_0005148) |
| Score Construction | |
| PGS Name | T2D_GRS |
| Development Method | |
| Name | Genome-wide significant SNPs |
| Parameters | P < 5 × 10−8 |
| Variants | |
| Original Genome Build | NR |
| Number of Variants | 37 |
| Effect Weight Type | beta |
| PGS Source | |
| PGS Catalog Publication (PGP) ID | PGP000834 |
| Citation (link to publication) | Wu S et al. Maturitas (2024) |
| Ancestry Distribution | |
| Source of Variant Associations (GWAS) | European: 100% 159,208 individuals (100%) |
| PGS Evaluation | European: 100% 1 Sample Sets |
| Study Identifiers | Sample Numbers | Sample Ancestry | Cohort(s) |
|---|---|---|---|
GWAS Catalog: GCST004773 Europe PMC: 28566273 |
159,208 individuals | European | NR |
|
PGS Performance Metric ID (PPM) |
PGS Sample Set ID (PSS) |
Performance Source | Trait |
PGS Effect Sizes (per SD change) |
Classification Metrics | Other Metrics | Covariates Included in the Model |
PGS Performance: Other Relevant Information |
|---|---|---|---|---|---|---|---|---|
| PPM036599 | PSS012320| European Ancestry| 146,343 individuals |
PGP000834 | Wu S et al. Maturitas (2024) |
Reported Trait: Incident type 2 diabetes | — | — | Hazard ratio (HR, high vs low tertile): 1.84 [1.71, 1.99] | Age at baseline, assessment center, genotyping batch, first ten genetic principal components | — |
| PPM036600 | PSS012320| European Ancestry| 146,343 individuals |
PGP000834 | Wu S et al. Maturitas (2024) |
Reported Trait: Incident type 2 diabetes x premature menopause interaction | — | — | Hazard ratio (HR, surgical premature menopause and high PRS vs. without premature menopause and low PRS): 2.61 [1.65, 4.12] | age, assessment centre, Townsend Deprivation index, alcohol consumption, smoking status, body mass index, physical activity, healthy diet score, serum total cholesterol, hypertension, cardiovascular disease, family history of diabetes, age at menarche, the use of hormone replacement therapy, the number of live births, genotyping batch, and the first ten genetic principal components | — |
|
PGS Sample Set ID (PSS) |
Phenotype Definitions and Methods | Participant Follow-up Time | Sample Numbers | Age of Study Participants | Sample Ancestry | Additional Ancestry Description | Cohort(s) | Additional Sample/Cohort Information |
|---|---|---|---|---|---|---|---|---|
| PSS012320 | — | — | 146,343 individuals, 0.0 % Male samples |
— | European | — | UKB | — |